

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of isotype switching to IgG isotypes (GO:0048302) | 9.56236485 |
| 2 | interferon-gamma production (GO:0032609) | 8.87499249 |
| 3 | cytidine metabolic process (GO:0046087) | 8.71551214 |
| 4 | cytidine catabolic process (GO:0006216) | 8.71551214 |
| 5 | cytidine deamination (GO:0009972) | 8.71551214 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 8.09183911 |
| 7 | positive thymic T cell selection (GO:0045059) | 7.96994002 |
| 8 | negative T cell selection (GO:0043383) | 7.85273270 |
| 9 | cellular response to interleukin-15 (GO:0071350) | 7.81862621 |
| 10 | negative thymic T cell selection (GO:0045060) | 7.78581899 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.63200318 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.61592592 |
| 13 | T cell migration (GO:0072678) | 7.28741476 |
| 14 | regulation of natural killer cell mediated immunity (GO:0002715) | 7.28394223 |
| 15 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 7.28394223 |
| 16 | DNA deamination (GO:0045006) | 6.87249016 |
| 17 | response to interleukin-15 (GO:0070672) | 6.76628102 |
| 18 | positive regulation of isotype switching (GO:0045830) | 6.70541921 |
| 19 | positive T cell selection (GO:0043368) | 6.69189851 |
| 20 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.45057250 |
| 21 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 6.39953696 |
| 22 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 6.39953696 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.38896533 |
| 24 | thymic T cell selection (GO:0045061) | 6.22333131 |
| 25 | positive regulation of DNA recombination (GO:0045911) | 6.12545558 |
| 26 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 5.99057141 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 5.87748918 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.85547210 |
| 29 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 5.74016700 |
| 30 | positive regulation of T cell cytokine production (GO:0002726) | 5.68835461 |
| 31 | regulation of cell killing (GO:0031341) | 5.64821042 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 5.64552393 |
| 33 | positive regulation of B cell mediated immunity (GO:0002714) | 5.61837185 |
| 34 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 5.61837185 |
| 35 | positive regulation of cell killing (GO:0031343) | 5.58523188 |
| 36 | leukocyte aggregation (GO:0070486) | 5.44735650 |
| 37 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.22807945 |
| 38 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 5.13537345 |
| 39 | T cell selection (GO:0045058) | 5.07722259 |
| 40 | regulation of isotype switching (GO:0045191) | 5.06778167 |
| 41 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.02682239 |
| 42 | positive regulation of defense response to virus by host (GO:0002230) | 4.99556258 |
| 43 | cytolysis (GO:0019835) | 4.97098476 |
| 44 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.84508339 |
| 45 | lymphocyte migration (GO:0072676) | 4.77649779 |
| 46 | activated T cell proliferation (GO:0050798) | 4.67044447 |
| 47 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.65843880 |
| 48 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.65682522 |
| 49 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.61407346 |
| 50 | sequestering of actin monomers (GO:0042989) | 4.55248548 |
| 51 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.54319754 |
| 52 | T cell receptor signaling pathway (GO:0050852) | 4.53108972 |
| 53 | natural killer cell activation (GO:0030101) | 4.46108492 |
| 54 | positive regulation of immunoglobulin production (GO:0002639) | 4.40926094 |
| 55 | regulation of B cell mediated immunity (GO:0002712) | 4.38688989 |
| 56 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.34309487 |
| 57 | T cell costimulation (GO:0031295) | 4.27588754 |
| 58 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 4.27209825 |
| 59 | positive regulation of lymphocyte migration (GO:2000403) | 4.22598508 |
| 60 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.22429995 |
| 61 | positive regulation of humoral immune response (GO:0002922) | 4.20824649 |
| 62 | heterotypic cell-cell adhesion (GO:0034113) | 4.20810252 |
| 63 | lymphocyte costimulation (GO:0031294) | 4.17515973 |
| 64 | regulation of lymphocyte mediated immunity (GO:0002706) | 4.16438200 |
| 65 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.07253442 |
| 66 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.03765368 |
| 67 | response to interferon-beta (GO:0035456) | 4.02419721 |
| 68 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.99472533 |
| 69 | cellular response to interferon-beta (GO:0035458) | 3.97954935 |
| 70 | * cellular defense response (GO:0006968) | 3.96450251 |
| 71 | negative regulation by host of viral transcription (GO:0043922) | 3.95821665 |
| 72 | positive regulation of T cell mediated immunity (GO:0002711) | 3.95764441 |
| 73 | regulation of T cell cytokine production (GO:0002724) | 3.82849747 |
| 74 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.82024867 |
| 75 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.80998332 |
| 76 | leukocyte cell-cell adhesion (GO:0007159) | 3.78461757 |
| 77 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.77881078 |
| 78 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.77881078 |
| 79 | T cell differentiation involved in immune response (GO:0002292) | 3.77881078 |
| 80 | regulation of immunoglobulin production (GO:0002637) | 3.76886156 |
| 81 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.75395302 |
| 82 | regulation of T-helper 1 type immune response (GO:0002825) | 3.73926689 |
| 83 | regulation of regulatory T cell differentiation (GO:0045589) | 3.70873578 |
| 84 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.70267481 |
| 85 | cellular extravasation (GO:0045123) | 3.68024302 |
| 86 | negative regulation of viral genome replication (GO:0045071) | 3.59485783 |
| 87 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.56728646 |
| 88 | regulation of response to interferon-gamma (GO:0060330) | 3.56646338 |
| 89 | regulation of hypersensitivity (GO:0002883) | 3.54013275 |
| 90 | regulation of memory T cell differentiation (GO:0043380) | 3.52980151 |
| 91 | regulation of T cell chemotaxis (GO:0010819) | 3.50200730 |
| 92 | positive regulation of T cell chemotaxis (GO:0010820) | 3.50200730 |
| 93 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.49540095 |
| 94 | regulation of T cell mediated immunity (GO:0002709) | 3.48806078 |
| 95 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.47774751 |
| 96 | negative regulation of adaptive immune response (GO:0002820) | 3.47754937 |
| 97 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.44688495 |
| 98 | positive regulation of type 2 immune response (GO:0002830) | 3.44056968 |
| 99 | negative regulation of metanephros development (GO:0072217) | 3.43812411 |
| 100 | cell wall macromolecule catabolic process (GO:0016998) | 3.42440524 |
| 101 | regulation of lymphocyte migration (GO:2000401) | 3.42192301 |
| 102 | T cell differentiation (GO:0030217) | 3.40063390 |
| 103 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.39892437 |
| 104 | regulation of B cell differentiation (GO:0045577) | 3.36712874 |
| 105 | lymphocyte chemotaxis (GO:0048247) | 3.34232146 |
| 106 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.33262189 |
| 107 | positive regulation of lamellipodium assembly (GO:0010592) | 3.33020851 |
| 108 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.32700563 |
| 109 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.32700563 |
| 110 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.30614765 |
| 111 | regulation of leukocyte mediated immunity (GO:0002703) | 3.30603886 |
| 112 | negative regulation of interleukin-2 production (GO:0032703) | 3.30345894 |
| 113 | mast cell activation (GO:0045576) | 3.26825063 |
| 114 | positive regulation of interleukin-10 production (GO:0032733) | 3.25175749 |
| 115 | positive regulation of T cell migration (GO:2000406) | 3.24230164 |
| 116 | B cell receptor signaling pathway (GO:0050853) | 3.23167483 |
| 117 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.21999116 |
| 118 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.21103187 |
| 119 | positive regulation of adaptive immune response (GO:0002821) | 3.19662736 |
| 120 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.19219245 |
| 121 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.18702668 |
| 122 | regulation of activation of Janus kinase activity (GO:0010533) | 3.17372370 |
| 123 | alpha-beta T cell differentiation (GO:0046632) | 3.16216006 |
| 124 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.16018988 |
| 125 | regulation of RIG-I signaling pathway (GO:0039535) | 3.14869145 |
| 126 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.12763851 |
| 127 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.12536469 |
| 128 | alpha-beta T cell activation (GO:0046631) | 3.11981332 |
| 129 | positive regulation of interferon-gamma production (GO:0032729) | 3.09571015 |
| 130 | eosinophil chemotaxis (GO:0048245) | 3.09380320 |
| 131 | leukocyte degranulation (GO:0043299) | 3.09257066 |
| 132 | T cell activation (GO:0042110) | 3.09217022 |
| 133 | regulation of defense response to virus by host (GO:0050691) | 3.08333480 |
| 134 | T cell proliferation (GO:0042098) | 3.07409435 |
| 135 | negative regulation of T cell apoptotic process (GO:0070233) | 3.07018628 |
| 136 | regulation of T cell tolerance induction (GO:0002664) | 3.06583727 |
| 137 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.00683107 |
| 138 | regulation of T cell migration (GO:2000404) | 3.00295824 |
| 139 | regulation of calcium-mediated signaling (GO:0050848) | 2.95317447 |
| 140 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.92240036 |
| 141 | negative regulation of cell killing (GO:0031342) | 10.7090830 |
| 142 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 10.7090830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.51605329 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.84803879 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.26033862 |
| 4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 5.09700923 |
| 5 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.46979765 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.43198794 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.05280047 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.97937089 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.56894004 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.55902454 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 3.24427525 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.05141846 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.98651139 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.92149770 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.62794508 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.55879986 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.43384557 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.17835041 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.14884865 |
| 20 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.06701471 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.04275657 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.98725501 |
| 23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97788502 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.91771784 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85883805 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84933770 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.78233000 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76599477 |
| 29 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.71294539 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70349272 |
| 31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.68019004 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66653491 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66368320 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65664092 |
| 35 | GATA3_26560356_Chip-Seq_TH2_Human | 1.59239274 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58943661 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.57276042 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56602083 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55902856 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.49492105 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49116798 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45477525 |
| 43 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.44361066 |
| 44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41560449 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41555176 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39204438 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38017980 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.36156253 |
| 49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27842196 |
| 50 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.27656810 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26701230 |
| 52 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25840712 |
| 53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25805144 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24578596 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23695973 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23386400 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23122231 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23102282 |
| 59 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.23093075 |
| 60 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.20605994 |
| 61 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20590280 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16725266 |
| 63 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16547208 |
| 64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16101792 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15285022 |
| 66 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14778591 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12476987 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11547693 |
| 69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10450176 |
| 70 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.09976016 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09819142 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08459558 |
| 73 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02522963 |
| 74 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02019749 |
| 75 | GATA3_26560356_Chip-Seq_TH1_Human | 1.01398134 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00455774 |
| 77 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99551646 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99115301 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97715650 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95604341 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94765065 |
| 82 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93292224 |
| 83 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.92190646 |
| 84 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.92042498 |
| 85 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91606594 |
| 86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89819158 |
| 87 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.89369002 |
| 88 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88943654 |
| 89 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88589558 |
| 90 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88571371 |
| 91 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86733172 |
| 92 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86510115 |
| 93 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.85069818 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84555711 |
| 95 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.84344372 |
| 96 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83579471 |
| 97 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.81846296 |
| 98 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.81390900 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81025418 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79371556 |
| 101 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.79137168 |
| 102 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.78091604 |
| 103 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.77770970 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77676316 |
| 105 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.76051313 |
| 106 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75475556 |
| 107 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.74699114 |
| 108 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.74699114 |
| 109 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 0.74396667 |
| 110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72664281 |
| 111 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.71978646 |
| 112 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.71521473 |
| 113 | AR_20517297_ChIP-Seq_VCAP_Human | 0.71347739 |
| 114 | P300_27268052_Chip-Seq_Bcells_Human | 0.71344827 |
| 115 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.71126755 |
| 116 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.71059890 |
| 117 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70276897 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69923066 |
| 119 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.69781007 |
| 120 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.68593957 |
| 121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.67051191 |
| 122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.67006816 |
| 123 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.66635440 |
| 124 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64705186 |
| 125 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.64468433 |
| 126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.61573064 |
| 127 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.61568653 |
| 128 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.61468610 |
| 129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.60527390 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.60435859 |
| 131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.59679759 |
| 132 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.58569405 |
| 133 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.55600772 |
| 134 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.55190605 |
| 135 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.55149224 |
| 136 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.54445894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.61180621 |
| 2 | MP0006082_CNS_inflammation | 5.10799401 |
| 3 | MP0003763_abnormal_thymus_physiology | 4.80501927 |
| 4 | MP0009785_altered_susceptibility_to | 4.24976889 |
| 5 | MP0001800_abnormal_humoral_immune | 3.19005020 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.10053712 |
| 7 | MP0005025_abnormal_response_to | 3.08530316 |
| 8 | MP0001873_stomach_inflammation | 2.97779004 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.90109902 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.83900272 |
| 11 | MP0001819_abnormal_immune_cell | 2.83099171 |
| 12 | MP0002723_abnormal_immune_serum | 2.78839468 |
| 13 | MP0002405_respiratory_system_inflammati | 2.71899725 |
| 14 | MP0003448_altered_tumor_morphology | 2.62552338 |
| 15 | MP0000685_abnormal_immune_system | 2.58983028 |
| 16 | MP0001790_abnormal_immune_system | 2.57706634 |
| 17 | MP0005387_immune_system_phenotype | 2.57706634 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.52541378 |
| 19 | MP0002006_tumorigenesis | 2.50511198 |
| 20 | MP0004947_skin_inflammation | 2.49129751 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.47263676 |
| 22 | MP0000858_altered_metastatic_potential | 2.46882672 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.43659864 |
| 24 | MP0002398_abnormal_bone_marrow | 2.38920826 |
| 25 | MP0002132_abnormal_respiratory_system | 2.36253981 |
| 26 | MP0003950_abnormal_plasma_membrane | 2.23650304 |
| 27 | MP0000716_abnormal_immune_system | 2.19137380 |
| 28 | MP0000569_abnormal_digit_pigmentation | 2.17103646 |
| 29 | MP0010234_abnormal_vibrissa_follicle | 2.07712228 |
| 30 | MP0002722_abnormal_immune_system | 2.05812855 |
| 31 | MP0000703_abnormal_thymus_morphology | 2.05310883 |
| 32 | MP0001986_abnormal_taste_sensitivity | 2.03138744 |
| 33 | MP0002419_abnormal_innate_immunity | 2.01661099 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.98772150 |
| 35 | MP0003045_fibrosis | 1.94757344 |
| 36 | MP0003724_increased_susceptibility_to | 1.94539927 |
| 37 | MP0004381_abnormal_hair_follicle | 1.90047910 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.87002309 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.84873042 |
| 40 | MP0002998_abnormal_bone_remodeling | 1.76546297 |
| 41 | MP0002429_abnormal_blood_cell | 1.68333397 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.63117362 |
| 43 | MP0002933_joint_inflammation | 1.51596214 |
| 44 | MP0003436_decreased_susceptibility_to | 1.51069408 |
| 45 | MP0003786_premature_aging | 1.49419525 |
| 46 | MP0008469_abnormal_protein_level | 1.40537554 |
| 47 | MP0002163_abnormal_gland_morphology | 1.40234273 |
| 48 | MP0003866_abnormal_defecation | 1.35912231 |
| 49 | MP0000372_irregular_coat_pigmentation | 1.35620167 |
| 50 | MP0002009_preneoplasia | 1.34336837 |
| 51 | MP0001851_eye_inflammation | 1.30956496 |
| 52 | MP0000613_abnormal_salivary_gland | 1.28827875 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.26090010 |
| 54 | MP0010307_abnormal_tumor_latency | 1.25080948 |
| 55 | MP0000920_abnormal_myelination | 1.19856893 |
| 56 | MP0005166_decreased_susceptibility_to | 1.17879844 |
| 57 | MP0002019_abnormal_tumor_incidence | 1.16056257 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.06698267 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.05682855 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.05370492 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.04172909 |
| 62 | MP0005451_abnormal_body_composition | 1.01654355 |
| 63 | MP0002876_abnormal_thyroid_physiology | 0.92575652 |
| 64 | MP0003183_abnormal_peptide_metabolism | 0.90447255 |
| 65 | MP0009763_increased_sensitivity_to | 0.89797204 |
| 66 | MP0001533_abnormal_skeleton_physiology | 0.87199728 |
| 67 | MP0003172_abnormal_lysosome_physiology | 0.86990729 |
| 68 | MP0004510_myositis | 0.85395130 |
| 69 | MP0008057_abnormal_DNA_replication | 0.84888076 |
| 70 | MP0008877_abnormal_DNA_methylation | 0.79102902 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.76533824 |
| 72 | MP0002136_abnormal_kidney_physiology | 0.76311974 |
| 73 | MP0005023_abnormal_wound_healing | 0.75586088 |
| 74 | MP0000490_abnormal_crypts_of | 0.75218797 |
| 75 | MP0005310_abnormal_salivary_gland | 0.73204667 |
| 76 | MP0001853_heart_inflammation | 0.72683620 |
| 77 | MP0003878_abnormal_ear_physiology | 0.71652616 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 0.71652616 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.71617701 |
| 80 | MP0002736_abnormal_nociception_after | 0.70996747 |
| 81 | MP0000343_altered_response_to | 0.70995952 |
| 82 | MP0001191_abnormal_skin_condition | 0.70982488 |
| 83 | MP0009764_decreased_sensitivity_to | 0.70380472 |
| 84 | MP0008569_lethality_at_weaning | 0.69467701 |
| 85 | MP0001881_abnormal_mammary_gland | 0.69419454 |
| 86 | MP0005408_hypopigmentation | 0.67214927 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 0.64553974 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.64110555 |
| 89 | MP0000609_abnormal_liver_physiology | 0.63925825 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.62512816 |
| 91 | MP0005075_abnormal_melanosome_morpholog | 0.62252204 |
| 92 | MP0005165_increased_susceptibility_to | 0.61965413 |
| 93 | MP0001661_extended_life_span | 0.61343090 |
| 94 | MP0005501_abnormal_skin_physiology | 0.60941308 |
| 95 | MP0005423_abnormal_somatic_nervous | 0.60730868 |
| 96 | MP0004742_abnormal_vestibular_system | 0.60723887 |
| 97 | MP0005360_urolithiasis | 0.60021527 |
| 98 | MP0001216_abnormal_epidermal_layer | 0.59953817 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.59081490 |
| 100 | MP0009643_abnormal_urine_homeostasis | 0.58706635 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.56339176 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.55795908 |
| 103 | MP0001968_abnormal_touch/_nociception | 0.53470266 |
| 104 | MP0003795_abnormal_bone_structure | 0.53216780 |
| 105 | MP0004147_increased_porphyrin_level | 0.52730950 |
| 106 | MP0008872_abnormal_physiological_respon | 0.52064369 |
| 107 | MP0005409_darkened_coat_color | 0.52042047 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.50253978 |
| 109 | MP0006072_abnormal_retinal_apoptosis | 0.48496778 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.47799840 |
| 111 | MP0003959_abnormal_lean_body | 0.46689434 |
| 112 | MP0000465_gastrointestinal_hemorrhage | 0.45762785 |
| 113 | MP0003646_muscle_fatigue | 0.45583324 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.45456632 |
| 115 | MP0000427_abnormal_hair_cycle | 0.44557459 |
| 116 | MP0002138_abnormal_hepatobiliary_system | 0.44044855 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.43838214 |
| 118 | MP0002060_abnormal_skin_morphology | 0.43274474 |
| 119 | MP0003303_peritoneal_inflammation | 0.43195077 |
| 120 | MP0001919_abnormal_reproductive_system | 0.43173572 |
| 121 | MP0008007_abnormal_cellular_replicative | 0.42938868 |
| 122 | MP0002168_other_aberrant_phenotype | 0.42392234 |
| 123 | MP0000477_abnormal_intestine_morphology | 0.42321898 |
| 124 | MP0002089_abnormal_postnatal_growth/wei | 0.41600154 |
| 125 | MP0001542_abnormal_bone_strength | 0.40592838 |
| 126 | MP0000627_abnormal_mammary_gland | 0.39754792 |
| 127 | MP0000015_abnormal_ear_pigmentation | 0.39649472 |
| 128 | MP0009379_abnormal_foot_pigmentation | 0.39607814 |
| 129 | MP0000367_abnormal_coat/_hair | 0.39320709 |
| 130 | MP0001243_abnormal_dermal_layer | 0.39135194 |
| 131 | MP0003136_yellow_coat_color | 0.35084102 |
| 132 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.34304298 |
| 133 | MP0008873_increased_physiological_sensi | 0.33862193 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.33715094 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.97062318 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.65592155 |
| 3 | Optic neuritis (HP:0100653) | 7.31429650 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 7.31429650 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 6.70374501 |
| 6 | Myositis (HP:0100614) | 6.51596053 |
| 7 | Orchitis (HP:0100796) | 6.32413805 |
| 8 | Combined immunodeficiency (HP:0005387) | 5.91975228 |
| 9 | Keratoconjunctivitis sicca (HP:0001097) | 5.27311511 |
| 10 | Keratoconjunctivitis (HP:0001096) | 4.77082697 |
| 11 | Thyroiditis (HP:0100646) | 4.77055561 |
| 12 | Encephalitis (HP:0002383) | 4.65700336 |
| 13 | Abnormality of T cells (HP:0002843) | 4.43478067 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.41627462 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 4.41627462 |
| 16 | Autoimmune hemolytic anemia (HP:0001890) | 4.25257895 |
| 17 | Hypoplasia of the thymus (HP:0000778) | 4.15805865 |
| 18 | Nasal polyposis (HP:0100582) | 4.03268125 |
| 19 | Joint swelling (HP:0001386) | 4.02578988 |
| 20 | Recurrent bronchitis (HP:0002837) | 3.95215771 |
| 21 | Meningitis (HP:0001287) | 3.93310790 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.87281712 |
| 23 | Granulocytopenia (HP:0001913) | 3.83431802 |
| 24 | Stomatitis (HP:0010280) | 3.82337645 |
| 25 | Chronic diarrhea (HP:0002028) | 3.74489588 |
| 26 | Hypoproteinemia (HP:0003075) | 3.71430774 |
| 27 | Increased IgM level (HP:0003496) | 3.70446330 |
| 28 | IgG deficiency (HP:0004315) | 3.69571387 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.63229849 |
| 30 | Abnormality of eosinophils (HP:0001879) | 3.63005542 |
| 31 | Recurrent fungal infections (HP:0002841) | 3.58297742 |
| 32 | Hemoptysis (HP:0002105) | 3.56781053 |
| 33 | Arterial thrombosis (HP:0004420) | 3.48058057 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.44312652 |
| 35 | Gangrene (HP:0100758) | 3.43703882 |
| 36 | Agammaglobulinemia (HP:0004432) | 3.35794017 |
| 37 | Pulmonary embolism (HP:0002204) | 3.24498331 |
| 38 | Pulmonary infiltrates (HP:0002113) | 3.23678004 |
| 39 | Abnormality of the nasal mucosa (HP:0000433) | 3.23574834 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 3.14315427 |
| 41 | Cutaneous melanoma (HP:0012056) | 3.03820747 |
| 42 | Leukocytosis (HP:0001974) | 2.98020152 |
| 43 | Vasculitis (HP:0002633) | 2.95526804 |
| 44 | Renal cortical cysts (HP:0000803) | 2.86449228 |
| 45 | Hemiplegia (HP:0002301) | 2.86313531 |
| 46 | Recurrent abscess formation (HP:0002722) | 2.85689911 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.83858661 |
| 48 | IgM deficiency (HP:0002850) | 2.73697501 |
| 49 | Anorexia (HP:0002039) | 2.70680660 |
| 50 | Recurrent skin infections (HP:0001581) | 2.67363919 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.59087433 |
| 52 | Keratitis (HP:0000491) | 2.52618248 |
| 53 | Abnormality of the common coagulation pathway (HP:0010990) | 2.48417952 |
| 54 | Pustule (HP:0200039) | 2.47565199 |
| 55 | Recurrent sinusitis (HP:0011108) | 2.45859530 |
| 56 | Obstructive lung disease (HP:0006536) | 2.43134329 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43134329 |
| 58 | 3-Methylglutaconic aciduria (HP:0003535) | 2.40340029 |
| 59 | Recurrent viral infections (HP:0004429) | 2.39865439 |
| 60 | Abnormality of macrophages (HP:0004311) | 2.37057354 |
| 61 | Abnormality of the prostate (HP:0008775) | 2.33079196 |
| 62 | Chronic otitis media (HP:0000389) | 2.31477578 |
| 63 | Lymphopenia (HP:0001888) | 2.28759668 |
| 64 | Increased IgE level (HP:0003212) | 2.27675605 |
| 65 | Lymphoma (HP:0002665) | 2.27492028 |
| 66 | Aplastic anemia (HP:0001915) | 2.26941552 |
| 67 | Glomerulopathy (HP:0100820) | 2.26077812 |
| 68 | Polyneuropathy (HP:0001271) | 2.24567577 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.24325495 |
| 70 | Abnormality of secondary sexual hair (HP:0009888) | 2.23612221 |
| 71 | Abnormality of the axillary hair (HP:0100134) | 2.23612221 |
| 72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.17861516 |
| 73 | Bronchitis (HP:0012387) | 2.17277041 |
| 74 | Abnormality of the fingertips (HP:0001211) | 2.16332592 |
| 75 | Colitis (HP:0002583) | 2.14736812 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.13780652 |
| 77 | Carpal bone hypoplasia (HP:0001498) | 2.13062910 |
| 78 | Tetraplegia (HP:0002445) | 2.10538503 |
| 79 | Abnormality of the pericardium (HP:0001697) | 2.07725777 |
| 80 | Inflammation of the large intestine (HP:0002037) | 2.05714629 |
| 81 | Microcytic anemia (HP:0001935) | 2.02930979 |
| 82 | Hypoalbuminemia (HP:0003073) | 2.01530801 |
| 83 | Abnormal albumin level (HP:0012116) | 2.01530801 |
| 84 | Eosinophilia (HP:0001880) | 2.00651218 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.00510090 |
| 86 | Increased serum ferritin (HP:0003281) | 2.00105656 |
| 87 | Thrombophlebitis (HP:0004418) | 1.96742692 |
| 88 | Ureteral stenosis (HP:0000071) | 1.93245154 |
| 89 | Alveolar cell carcinoma (HP:0006519) | 1.93004754 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 1.92419474 |
| 91 | Porencephaly (HP:0002132) | 1.92323448 |
| 92 | Gastrointestinal inflammation (HP:0004386) | 1.91513379 |
| 93 | Arthropathy (HP:0003040) | 1.91231037 |
| 94 | Recurrent otitis media (HP:0000403) | 1.89637166 |
| 95 | Gingivitis (HP:0000230) | 1.89624751 |
| 96 | Abnormality of the endocardium (HP:0004306) | 1.88802695 |
| 97 | Arthralgia (HP:0002829) | 1.88749757 |
| 98 | Squamous cell carcinoma (HP:0002860) | 1.85543798 |
| 99 | IgA deficiency (HP:0002720) | 1.84883297 |
| 100 | Sepsis (HP:0100806) | 1.83270513 |
| 101 | Acne (HP:0001061) | 1.82670998 |
| 102 | Abnormal platelet volume (HP:0011876) | 1.79533451 |
| 103 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.78090785 |
| 104 | Fair hair (HP:0002286) | 1.77913069 |
| 105 | Conical tooth (HP:0000698) | 1.77526971 |
| 106 | Progressive inability to walk (HP:0002505) | 1.77134247 |
| 107 | Skin rash (HP:0000988) | 1.73344915 |
| 108 | Spontaneous hematomas (HP:0007420) | 1.73316435 |
| 109 | Prolonged neonatal jaundice (HP:0006579) | 1.71844401 |
| 110 | Recurrent bacterial skin infections (HP:0005406) | 1.71515802 |
| 111 | Dry hair (HP:0011359) | 1.71214260 |
| 112 | Anhidrosis (HP:0000970) | 1.71100185 |
| 113 | Duplicated collecting system (HP:0000081) | 1.71005521 |
| 114 | Congenital stationary night blindness (HP:0007642) | 1.70668616 |
| 115 | Diplopia (HP:0000651) | 1.70529774 |
| 116 | Abnormality of binocular vision (HP:0011514) | 1.70529774 |
| 117 | Congenital, generalized hypertrichosis (HP:0004540) | 1.70403105 |
| 118 | Vertigo (HP:0002321) | 1.70245929 |
| 119 | Abnormality of oral frenula (HP:0000190) | 1.70165393 |
| 120 | Thrombocytosis (HP:0001894) | 1.69977414 |
| 121 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.69769786 |
| 122 | Lower limb hyperreflexia (HP:0002395) | 1.69264113 |
| 123 | Basal ganglia calcification (HP:0002135) | 1.68877432 |
| 124 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.66915818 |
| 125 | Hepatosplenomegaly (HP:0001433) | 1.66770233 |
| 126 | Pancreatic cysts (HP:0001737) | 1.66081324 |
| 127 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.65690748 |
| 128 | Ureteral obstruction (HP:0006000) | 1.64641438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.54438330 |
| 2 | MAP3K12 | 3.87144559 |
| 3 | MAP4K1 | 3.78425306 |
| 4 | ITK | 3.62360594 |
| 5 | FGFR4 | 3.17261936 |
| 6 | JAK1 | 2.93801488 |
| 7 | CSK | 2.67491364 |
| 8 | TYK2 | 2.63592478 |
| 9 | JAK3 | 2.50814310 |
| 10 | ZAP70 | 2.42448228 |
| 11 | SRPK1 | 2.41038524 |
| 12 | IKBKE | 2.22927204 |
| 13 | MAP2K6 | 2.13423473 |
| 14 | MAP3K14 | 2.02735224 |
| 15 | FGFR3 | 1.91382905 |
| 16 | BLK | 1.89841830 |
| 17 | TGFBR2 | 1.77596118 |
| 18 | LCK | 1.72896462 |
| 19 | KIT | 1.67749397 |
| 20 | MAP3K11 | 1.60757905 |
| 21 | KDR | 1.59341619 |
| 22 | GRK7 | 1.55223370 |
| 23 | TNK2 | 1.52958034 |
| 24 | TBK1 | 1.52755555 |
| 25 | STK10 | 1.51079360 |
| 26 | DAPK2 | 1.48465018 |
| 27 | NEK9 | 1.46527951 |
| 28 | IRAK4 | 1.45929876 |
| 29 | ADRBK2 | 1.44433093 |
| 30 | NUAK1 | 1.43391691 |
| 31 | CDK3 | 1.42141872 |
| 32 | MAP2K3 | 1.37657221 |
| 33 | MAP3K3 | 1.29387731 |
| 34 | PRKCH | 1.27271462 |
| 35 | MST4 | 1.24485805 |
| 36 | MAPKAPK3 | 1.24322962 |
| 37 | IRAK1 | 1.12487639 |
| 38 | MATK | 1.12144818 |
| 39 | SYK | 1.11695944 |
| 40 | BCR | 1.06693666 |
| 41 | CLK1 | 1.06029215 |
| 42 | MYLK | 1.04229417 |
| 43 | BTK | 1.01475987 |
| 44 | PRKCQ | 1.00459711 |
| 45 | HCK | 0.96508830 |
| 46 | EPHB1 | 0.95952063 |
| 47 | NLK | 0.94234324 |
| 48 | SIK3 | 0.92286984 |
| 49 | GRK5 | 0.91654966 |
| 50 | MAP3K7 | 0.90582117 |
| 51 | LYN | 0.89168073 |
| 52 | NTRK1 | 0.89146632 |
| 53 | TLK1 | 0.89041964 |
| 54 | MAP3K13 | 0.88719341 |
| 55 | MOS | 0.88700987 |
| 56 | WNK4 | 0.88457381 |
| 57 | GRK6 | 0.86493227 |
| 58 | PIK3CA | 0.83388478 |
| 59 | FER | 0.81658672 |
| 60 | TESK2 | 0.80917031 |
| 61 | PIK3CG | 0.80795320 |
| 62 | IRAK3 | 0.79763670 |
| 63 | SIK2 | 0.79683368 |
| 64 | EIF2AK2 | 0.77246678 |
| 65 | STK39 | 0.74500598 |
| 66 | MAPKAPK2 | 0.73742438 |
| 67 | TEC | 0.73581021 |
| 68 | NME2 | 0.72400398 |
| 69 | TAOK1 | 0.72201823 |
| 70 | FYN | 0.68729526 |
| 71 | TAOK2 | 0.68359731 |
| 72 | JAK2 | 0.68159003 |
| 73 | FES | 0.64965733 |
| 74 | MAP3K1 | 0.64277188 |
| 75 | NEK2 | 0.63329666 |
| 76 | BUB1 | 0.62950590 |
| 77 | CAMKK2 | 0.61449060 |
| 78 | IGF1R | 0.60589363 |
| 79 | ALK | 0.59788521 |
| 80 | CHUK | 0.59406390 |
| 81 | CASK | 0.58519332 |
| 82 | CDK4 | 0.58314297 |
| 83 | TTN | 0.58003423 |
| 84 | EPHA3 | 0.56947210 |
| 85 | PIM1 | 0.56735929 |
| 86 | MAP3K10 | 0.53842252 |
| 87 | CSF1R | 0.52301711 |
| 88 | FGFR1 | 0.52108264 |
| 89 | RIPK4 | 0.50403914 |
| 90 | RPS6KA5 | 0.49416664 |
| 91 | MAPK13 | 0.48653175 |
| 92 | MELK | 0.48562361 |
| 93 | MAPK11 | 0.47514814 |
| 94 | SIK1 | 0.44066523 |
| 95 | MARK2 | 0.42666874 |
| 96 | CDK8 | 0.42367439 |
| 97 | INSR | 0.42221684 |
| 98 | ILK | 0.41317769 |
| 99 | IKBKB | 0.41000919 |
| 100 | HIPK2 | 0.40507186 |
| 101 | CSNK1A1L | 0.40323813 |
| 102 | MST1R | 0.38593991 |
| 103 | CSNK1A1 | 0.38484060 |
| 104 | DAPK3 | 0.38384142 |
| 105 | EIF2AK3 | 0.37064959 |
| 106 | MAP2K7 | 0.36775946 |
| 107 | PAK4 | 0.35899846 |
| 108 | MARK3 | 0.35034173 |
| 109 | INSRR | 0.33999292 |
| 110 | RET | 0.32811337 |
| 111 | PRKG2 | 0.32322083 |
| 112 | STK24 | 0.31259894 |
| 113 | LRRK2 | 0.30820478 |
| 114 | OXSR1 | 0.29429592 |
| 115 | CDC7 | 0.29236129 |
| 116 | CSNK1D | 0.29021518 |
| 117 | BRD4 | 0.28490081 |
| 118 | PRKD2 | 0.28217681 |
| 119 | TAOK3 | 0.27844927 |
| 120 | PRKCD | 0.27415482 |
| 121 | GSK3A | 0.24132008 |
| 122 | CDK9 | 0.24033681 |
| 123 | MAP2K2 | 0.22631488 |
| 124 | RPS6KA4 | 0.22595313 |
| 125 | DAPK1 | 0.21924437 |
| 126 | DMPK | 0.21778201 |
| 127 | ROCK2 | 0.21549299 |
| 128 | ACVR1B | 0.21523672 |
| 129 | CDK12 | 0.20733510 |
| 130 | RIPK1 | 0.20220226 |
| 131 | BMPR2 | 0.19931714 |
| 132 | ADRBK1 | 0.19723698 |
| 133 | ZAK | 0.19223169 |
| 134 | SRC | 0.18913515 |
| 135 | ATR | 0.18623406 |
| 136 | ABL1 | 0.18055363 |
| 137 | MAPK12 | 0.17939913 |
| 138 | CSNK1G1 | 0.17906871 |
| 139 | PRKCI | 0.17210507 |
| 140 | PDK1 | 0.16982625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 9.77605312 |
| 2 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.78910430 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.40267062 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 4.30300946 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.73462229 |
| 6 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 3.48692260 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.71339601 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.63673537 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.55030340 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.07776983 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 1.94818825 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 1.88840468 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.69401075 |
| 14 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.67355883 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63957185 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.51715670 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.50859260 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47236326 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.38114280 |
| 20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35841467 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24783421 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.24003500 |
| 23 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.16222140 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11580781 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07657809 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02724732 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00534049 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99668282 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95956010 |
| 30 | RNA polymerase_Homo sapiens_hsa03020 | 0.95474101 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93892827 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93049017 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91254016 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84052571 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82765029 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80851742 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 0.80755424 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80020413 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74971833 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 0.74518809 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65891781 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61898650 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61059405 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59635582 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58474897 |
| 46 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57262406 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56091390 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52296516 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.52128367 |
| 50 | Asthma_Homo sapiens_hsa05310 | 0.50053197 |
| 51 | Protein export_Homo sapiens_hsa03060 | 0.49251992 |
| 52 | Ribosome_Homo sapiens_hsa03010 | 0.49132972 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.46589945 |
| 54 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46284215 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45588527 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.45378459 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45276551 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43925804 |
| 59 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.43036357 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 0.42757874 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41170965 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.40028223 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37699051 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37407268 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36178977 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.31951970 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31738371 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.31129002 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 0.31108529 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.30439425 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29727116 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 0.29096800 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28870224 |
| 74 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.25920991 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.25516401 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.23248173 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23087931 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.22937362 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.21668556 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20182244 |
| 81 | Basal transcription factors_Homo sapiens_hsa03022 | 0.19957080 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.18541819 |
| 83 | Spliceosome_Homo sapiens_hsa03040 | 0.18383776 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.17994534 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.17107101 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.16978590 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.16922099 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.16080891 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.15394311 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.15067135 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.14705456 |
| 92 | Homologous recombination_Homo sapiens_hsa03440 | 0.14293356 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14017369 |
| 94 | Parkinsons disease_Homo sapiens_hsa05012 | 0.13480848 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13173911 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.13128098 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.13031786 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.12393823 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10391032 |
| 100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.10150006 |
| 101 | Purine metabolism_Homo sapiens_hsa00230 | 0.08941146 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.08768723 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.08707799 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | 0.08205094 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07330692 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.07219807 |
| 107 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.07191868 |
| 108 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.07120088 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.07119272 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.05385681 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.04898813 |
| 112 | Adherens junction_Homo sapiens_hsa04520 | 0.03275299 |
| 113 | ABC transporters_Homo sapiens_hsa02010 | 0.02770729 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.01626072 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.01461482 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.01274939 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.00426775 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | -0.0571407 |
| 119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0540590 |
| 120 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | -0.0495096 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | -0.0429967 |
| 122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | -0.0422649 |
| 123 | Pathways in cancer_Homo sapiens_hsa05200 | -0.0389494 |
| 124 | Mismatch repair_Homo sapiens_hsa03430 | -0.0331915 |
| 125 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0306867 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | -0.0280786 |
| 127 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | -0.0236177 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0221129 |
| 129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | -0.0181333 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | -0.0157937 |
| 131 | Morphine addiction_Homo sapiens_hsa05032 | -0.0139317 |
| 132 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0133113 |
| 133 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0129724 |
| 134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0007516 |

